Glaucoma Therapeutics Market Report

Global and Region Glaucoma Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：228
  • REPORT CODE：GMM1016974
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Glaucoma is a disease of eye which is caused by excessive increase of fluid pressure within the eye. Glaucoma is caused due to mechanical compression or decreased blood flow in the optic nerve of the patient’s eye. If not treated properly, it may lead to mild loss of vision and even blindness. Treatment of glaucoma includes laser therapies, pharmaceutical drugs and surgical procedures.

    The report details the trend, potential and market size of Glaucoma Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Glaucoma Therapeuticsmarket, defines the market attractiveness level of Glaucoma Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Glaucoma Therapeutics industry, describes the types of Glaucoma Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Glaucoma Therapeutics market and the development prospects and opportunities of Glaucoma Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Glaucoma Therapeutics market in Chapter 13.

    By Player:

    • Novartis

    • Merck

    • Aerie Pharmaceuticals

    • Santen Pharmaceuticals

    • Pfizer

    • Allergan

    • Valeant Pharmaceuticals

    By Type:

    • Beta Blockers

    • Prostaglandin

    • Latanoprost

    • Bimatoprost

    • Travoprost

    • Alpha adrenergic Agonist

    • Carbonic Anhydrase Inhibitor

    • Combinations Drugs

    • Others

    By End-User:

    • Hospitals

    • Ophthalmic Clinics

    • Ambulatory Surgical Centers

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Glaucoma Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Glaucoma Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Glaucoma Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Glaucoma Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Glaucoma Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Glaucoma Therapeutics Consumption (2017-2022)

    • 7.2 United States Glaucoma Therapeutics Consumption (2017-2022)

    • 7.3 Europe Glaucoma Therapeutics Consumption (2017-2022)

    • 7.4 China Glaucoma Therapeutics Consumption (2017-2022)

    • 7.5 Japan Glaucoma Therapeutics Consumption (2017-2022)

    • 7.6 India Glaucoma Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Glaucoma Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Glaucoma Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Glaucoma Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Glaucoma Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Glaucoma Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Glaucoma Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Glaucoma Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Glaucoma Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Glaucoma Therapeutics Consumption Forecast (2022-2028)

    9 Global Glaucoma Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Glaucoma Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Beta Blockers Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Prostaglandin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Latanoprost Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Bimatoprost Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Travoprost Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Alpha adrenergic Agonist Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Carbonic Anhydrase Inhibitor Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Combinations Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Glaucoma Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Ophthalmic Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    10 Global Glaucoma Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Glaucoma Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Beta Blockers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Prostaglandin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Latanoprost Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Bimatoprost Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Travoprost Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Alpha adrenergic Agonist Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Carbonic Anhydrase Inhibitor Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Combinations Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Glaucoma Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Ophthalmic Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    11 Global Glaucoma Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Glaucoma Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Glaucoma Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Glaucoma Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Glaucoma Therapeutics Market Competitive Analysis

    • 14.1 Novartis

      • 14.1.1 Novartis Company Details

      • 14.1.2 Novartis Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis Glaucoma Therapeutics Product and Service

    • 14.2 Merck

      • 14.2.1 Merck Company Details

      • 14.2.2 Merck Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck Glaucoma Therapeutics Product and Service

    • 14.3 Aerie Pharmaceuticals

      • 14.3.1 Aerie Pharmaceuticals Company Details

      • 14.3.2 Aerie Pharmaceuticals Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Aerie Pharmaceuticals Glaucoma Therapeutics Product and Service

    • 14.4 Santen Pharmaceuticals

      • 14.4.1 Santen Pharmaceuticals Company Details

      • 14.4.2 Santen Pharmaceuticals Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Santen Pharmaceuticals Glaucoma Therapeutics Product and Service

    • 14.5 Pfizer

      • 14.5.1 Pfizer Company Details

      • 14.5.2 Pfizer Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Glaucoma Therapeutics Product and Service

    • 14.6 Allergan

      • 14.6.1 Allergan Company Details

      • 14.6.2 Allergan Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Allergan Glaucoma Therapeutics Product and Service

    • 14.7 Valeant Pharmaceuticals

      • 14.7.1 Valeant Pharmaceuticals Company Details

      • 14.7.2 Valeant Pharmaceuticals Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Valeant Pharmaceuticals Glaucoma Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Glaucoma Therapeutics

    • Figure Glaucoma Therapeutics Picture

    • Table Global Glaucoma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Glaucoma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Glaucoma Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Glaucoma Therapeutics Consumption by Country (2017-2022)

    • Figure United States Glaucoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Glaucoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Glaucoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Glaucoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Glaucoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Glaucoma Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Glaucoma Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Glaucoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Glaucoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Glaucoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Glaucoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Glaucoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Glaucoma Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Beta Blockers Consumption and Growth Rate (2017-2022)

    • Figure Global Prostaglandin Consumption and Growth Rate (2017-2022)

    • Figure Global Latanoprost Consumption and Growth Rate (2017-2022)

    • Figure Global Bimatoprost Consumption and Growth Rate (2017-2022)

    • Figure Global Travoprost Consumption and Growth Rate (2017-2022)

    • Figure Global Alpha adrenergic Agonist Consumption and Growth Rate (2017-2022)

    • Figure Global Carbonic Anhydrase Inhibitor Consumption and Growth Rate (2017-2022)

    • Figure Global Combinations Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Ophthalmic Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Beta Blockers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostaglandin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Latanoprost Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bimatoprost Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Travoprost Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alpha adrenergic Agonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Carbonic Anhydrase Inhibitor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Combinations Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ophthalmic Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Glaucoma Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Glaucoma Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Glaucoma Therapeutics Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Glaucoma Therapeutics Product and Service

    • Table Aerie Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Aerie Pharmaceuticals Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aerie Pharmaceuticals Glaucoma Therapeutics Product and Service

    • Table Santen Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Santen Pharmaceuticals Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Santen Pharmaceuticals Glaucoma Therapeutics Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Glaucoma Therapeutics Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Glaucoma Therapeutics Product and Service

    • Table Valeant Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Valeant Pharmaceuticals Glaucoma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Glaucoma Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US